The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksASH.L Regulatory News (ASH)

  • There is currently no data for ASH

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Sale of Interest in Morgan Ashley

21 Oct 2019 07:00

RNS Number : 4625Q
Ashley House PLC
21 October 2019
 

21 October 2019

 

Ashley House plc

("Ashley House", the "Company" or the "Group")

 

Sale of Interest in Morgan Ashley

Re-focus on health and modular sectors

 

Ashley House plc, the health and community care property partner, announces that, further to the Trading Update released on 1st August 2019 and its process of reviewing various financing and strategic options, the Company has completed on a sale of its 50 per cent interest in Morgan Ashley Care Developments LLP ("Morgan Ashley"), to its joint venture partner Morgan Sindall Investments Limited ("MSI"), (the "Transaction").

Consideration for the Transaction is £2,000,000 payable in cash, £500,000 of which is to be deferred and expected to be received in instalments over the next twelve months including £200,000 which is dependent on the monies being generated from a particular scheme. In addition, the Company has signed an agreement with MSI for Ashley House to work on a pipeline of health, wellbeing and primary care developments across established health partnerships within which MSI are already working. The Company views this as an opportunity to work closely with the NHS and partners (very much the origins of the Ashley House business) to deliver much needed innovative health, wellbeing and primary care facilities.

As previously announced, delays to Morgan Ashley schemes reaching financial close have had a significant impact on the cash requirements of that business. Since the creation of Morgan Ashley it has required funding from Ashley House and MSI. Notwithstanding this, Ashley House's share of the profits from the Morgan Ashley joint venture contributed £310,000 in the year to 30 April 2018. Having explored a number of funding solutions including both debt and equity, the Company has concluded that the Transaction is in the best interests of shareholders. The Transaction will satisfy the short term cash requirements and enable Ashley House to restructure and return its focus to its key strengths as a developer of health and wellness buildings, as well as driving opportunities for its majority owned modular business, F1 Modular.

The terms of the Transaction restrict Ashley House from working in the elderly care housing sector for a period of three years, but the Board is developing a strategy to enable it to broaden its sphere of activity to adjacent markets, such as affordable housing and healthcare which are not restricted by the terms of the Transaction. Twelve staff members will transfer to Morgan Sindall under TUPE and the central management function of the Group is being restructured to be appropriate going forward, resulting in cost savings. The proceeds of the Transaction will be deployed within key areas of focus and used to support the Group's working capital requirements.

Antony Walters, Chief Executive, said: "The Board has reviewed funding and strategic opportunities available for the Company and has concluded that the Transaction and a re-focus on its key strengths in health development and modular construction are the most suitable options. We look forward to being able to exploit opportunities in these sectors and further developing the Company's strategic reach."

This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) No. 596/2014.

 

Enquiries:

Ashley House plc

01628 600 340

Antony Walters

Jonathan Holmes

James Hathaway

WH Ireland Ltd

0207 220 1666

(Nominated Adviser and broker)

Adrian Hadden

James Sinclair-Ford

Darshan Patel

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DISEAPEEAAKNFFF
Date   Source Headline
29th Jun 20189:08 amRNSDirectorate change
10th May 20187:00 amRNSHolding(s) in Company
9th May 20182:05 pmRNSSecond Price Monitoring Extn
9th May 20182:00 pmRNSPrice Monitoring Extension
9th May 20187:00 amRNSTrading Update
3rd May 20185:38 pmRNSDirector/PDMR Shareholding
6th Mar 20183:00 pmRNSDirector Dealing
5th Mar 20187:00 amRNSFinancial Close Scarborough Extra Care
1st Mar 20187:00 amRNSAppointment of Finance Director
23rd Feb 201811:54 amRNSHolding(s) in Company
14th Feb 20188:51 amRNSSale of Pharmacy Interest to Repay Debt - Amended
14th Feb 20187:00 amRNSSale of Pharmacy Interest to Repay Debt
2nd Feb 20189:32 amRNSHolding(s) in Company
31st Jan 20187:00 amRNSInterim Results
30th Jan 20184:31 pmRNSDirectors' & PDMRs' Dealings
22nd Dec 20171:07 pmRNSDirector/PDMR Shareholding
15th Dec 20171:56 pmRNSJoint Venture with Morgan Sindall Investments Ltd
24th Nov 20177:00 amRNSUpdate
7th Nov 201711:00 amRNSHolding(s) in Company
31st Oct 20172:28 pmRNSDirectors' & PDMRs' Dealings
26th Oct 20177:00 amRNSUpdate
25th Oct 201712:35 pmRNSResult of AGM
3rd Oct 201710:45 amRNSHolding(s) in Company
3rd Oct 20179:25 amRNSHolding(s) in Company
2nd Oct 20177:00 amRNSPreliminary Results For The Year End 30 April 2017
28th Jul 20174:45 pmRNSDirectors' & PDMRs' Dealings
4th Jul 20174:27 pmRNSDebt Facility from Related Party
28th Apr 20172:20 pmRNSDirectors' & PDMRs' dealings
25th Apr 20173:16 pmRNSDebt Facility from Related Party
27th Mar 201711:09 amRNSDirector Dealing
17th Mar 20173:42 pmRNSDirector Dealing
14th Mar 20171:11 pmRNSAcquisition and Trading Update
22nd Feb 201712:03 pmRNSPosting of Interim Report
30th Jan 20171:27 pmRNSDirectors' & PDMRs' dealings
26th Jan 20177:00 amRNSInterim Report 2016
17th Jan 201710:27 amRNSHolding(s) in Company
7th Dec 20167:00 amRNSReplacement Debt Facility from Related Party
28th Oct 20168:41 amRNSDirectors' & PDMRs' dealings
15th Sep 201610:48 amRNSResult of AGM
23rd Aug 20167:00 amRNSReport and Accounts / AGM
28th Jul 20167:00 amRNSDirectors' & PDMRs' Dealings
13th Jul 201611:58 amRNSDirector/PDMR Shareholding
13th Jul 20167:00 amRNSPreliminary results
29th Apr 20167:00 amRNSTotal Voting Rights
28th Apr 201610:22 amRNSDirectors' & PDMRs' dealings
29th Mar 20167:00 amRNSDirectors & PDMRs dealings
1st Mar 201611:09 amRNSDirector Dealing
10th Feb 20167:00 amRNSAdmission Application Announcement
5th Feb 20165:27 pmRNSPosting of Interim Report
26th Jan 20167:00 amRNSInterim Report 2015

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.